Esten N. Vandsemb
-
- CAR-T cell therapy research 2
- Peptidase Inhibition and Analysis 2
- Cytokine Signaling Pathways and Interactions 2
-
- Multiple Myeloma Research and Treatments 7
-
- Protein Tyrosine Phosphatases 7
- Ubiquitin and proteasome pathways 4
- PI3K/AKT/mTOR signaling in cancer 4
- Protein Kinase Regulation and GTPase Signaling 2
- Co-authors
- Roy S. HerbstLieping ChenTae Kon KimMagne BørsetTobias S. SlørdahlTorstein B. RøAnne‐Marit SponaasKristine Misund
- Cited by
- ImmunologyOncologyHematology
- Partner nations
- NorwayUnited StatesBelgium
In The Last Decade
Esten N. Vandsemb
15 papers receiving 404 citations
Hit Papers
Peers
Comparison fields: 5 of 54
- Immunology 174
- Oncology 181
- Hematology 46
- Molecular Biology 209
- Cancer Research 43
Countries citing papers authored by Esten N. Vandsemb
This map shows the geographic impact of Esten N. Vandsemb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esten N. Vandsemb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esten N. Vandsemb more than expected).
Fields of papers citing papers by Esten N. Vandsemb
This network shows the impact of papers produced by Esten N. Vandsemb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esten N. Vandsemb. The network helps show where Esten N. Vandsemb may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Esten N. Vandsemb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunitiesbreakdown → | 2022 | 244 |
| 3 | 2022 | 1 | |
| 4 | 2022 | 5 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 10 | |
| 7 | 2021 | 4 | |
| 8 | 2021 | 21 | |
| 9 | 2021 | 3 | |
| 10 | 2021 | 18 | |
| 11 | 2018 | 11 | |
| 12 | 2017 | 17 | |
| 13 | 2016 | 17 | |
| 14 | 2016 | 27 | |
| 15 | 2016 | 28 |
About Esten N. Vandsemb
Esten N. Vandsemb is a scholar working on Hematology, Oncology and Immunology, having authored 15 papers that have together received 408 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (7 papers), Protein Tyrosine Phosphatases (7 papers), Ubiquitin and proteasome pathways (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), CAR-T cell therapy research (2 papers), Peptidase Inhibition and Analysis (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Immunology (174 citations), Oncology (181 citations) and Hematology (46 citations). Esten N. Vandsemb has collaborated with scholars based in Norway, United States and Belgium. Frequent co-authors include Roy S. Herbst, Lieping Chen, Tae Kon Kim, Magne Børset, Tobias S. Slørdahl, Torstein B. Rø, Anne‐Marit Sponaas, Kristine Misund, Morten Beck Rye and Marita Westhrin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.